Clinical Trial Update: Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of neoadjuvant chemotherapy including sorafenib in women with untreated primary breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED